About PTX
Prescient Therapeutics (PTX) is a clinical stage oncology company developing personalised medicine approaches to cancer, including targeted and cellular therapies.
Find out what a historical investment in Prescient Therapeutics would be worth today using our PTX stock calculator.
Market Capitalisation
$73.21M
Price-earnings ratio
-9.71
Dividend yield
-
High today
$0.07
Low today
$0.06
Open price
$0.07
52-week high
$0.13
52-week low
$0.04
Ready to start your investing journey with Stake?
Open an accountAnnouncements
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in PTX
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in PTX on Stake
- Buy PTX from A$3 brokerage
- Invest in 2,500+ Aussie stocks and ETFs
- CHESS-sponsored ASX trades
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
PTX related stocks